Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients
试验速览
- 阶段
- 3 期
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- number of muscle cramps
研究概览
简要总结
Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.
详细描述
Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Abrams et al compared patients with cirrhosis with those with congestive heart failure and found a significantly higher prevalence of weekly or daily cramps with cirrhosis (22%) vs patients with congestive heart failure (5%). Interestingly, there was no difference in diuretic use or dosing between the 2 groups, supporting that factors other than diuretic-mediated effects explained the differences. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Cirrhotic patients with frequent muscle cramps.
排除标准
- •Elderly patients.
- •Encephalopathy
研究组 & 干预措施
Methocarbamol
Methocarbamol twice daily
干预措施: Methocarbamol (Drug)
placebo
Calcium carbonate twice daily
干预措施: Calcium Carbonate (Drug)
结局指标
主要结局
number of muscle cramps
时间窗: 3 months
change in number of muscle cramps
次要结局
未报告次要终点
研究者
Sherief Abd-Elsalam
Consultant liver and GIT diseases- Tanta university hospital
Tanta University
